Search research articles
Contact Us
Filters
Showing results (41-50 of 117) with videos related to
Page
of 12
Sort By:
The New England Journal of Medicine
|
March 13, 2024
Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma
Bryan D Choi, Elizabeth R Gerstner, Matthew J Frigault, et al.
Leukemia
|
December 19, 2025
Prognostic value of serological and PET/CT response kinetics in patients with multiple myeloma treated with BCMA CAR-T
Joshua N Gustine, John A Scaringi, Fabian Bauer, et al.
Blood
|
May 28, 2020
Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19?
Matthew J Frigault, Sarah Nikiforow, Michael K Mansour, et al.
Blood Cancer Journal
|
November 1, 2022
Effect of granulocyte colony-stimulating factor on toxicities after CAR T cell therapy for lymphoma and myeloma
Kevin Charles Miller, Patrick Connor Johnson, Jeremy S Abramson, et al.
Transplantation and Cellular Therapy
|
February 15, 2026
Incidence of and Risk Factors for Delayed Engraftment after Post-Transplant Cyclophosphamide
Lauren Scarpetti, Daniel E Schwartz, Weixing Huang, et al.
Blood
|
April 21, 2021
Primary resistance to CD19-directed chimeric antigen receptor T-cell therapy in T-cell/histiocyte-rich large B-cell lymphoma
Jonathan A Trujillo, James Godfrey, Yifei Hu, et al.
Blood Advances
|
June 25, 2025
Invasive fungal disease is rare in patients with relapsed/refractory multiple myeloma treated with BCMA CAR T-cell therapy
Jessica S Little, Angelica Medina Pena, E Bridget Kim, et al.
Journal for Immunotherapy of Cancer
|
May 9, 2024
Stealth transgenes enable CAR-T cells to evade host immune responses
Korneel Grauwet, Trisha Berger, Michael C Kann, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
January 25, 2020
Acute Kidney Injury and Electrolyte Abnormalities After Chimeric Antigen Receptor T-Cell (CAR-T) Therapy for Diffuse Large B-Cell Lymphoma
Shruti Gupta, Harish Seethapathy, Ian A Strohbehn, et al.
Bone Marrow Transplantation
|
October 11, 2023
Low incidence of engraftment syndrome following allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide
Daniel J Ikeda, Zachariah DeFilipp, Kerry Collier, et al.
Page
of 12
Search research articles
Search
Showing results (41-50 of 117) with videos related to
Sort By:
Page
of 12
The New England Journal of Medicine
|
March 13, 2024
Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma
Bryan D Choi, Elizabeth R Gerstner, Matthew J Frigault, et al.
Leukemia
|
December 19, 2025
Prognostic value of serological and PET/CT response kinetics in patients with multiple myeloma treated with BCMA CAR-T
Joshua N Gustine, John A Scaringi, Fabian Bauer, et al.
Blood
|
May 28, 2020
Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19?
Matthew J Frigault, Sarah Nikiforow, Michael K Mansour, et al.
Blood Cancer Journal
|
November 1, 2022
Effect of granulocyte colony-stimulating factor on toxicities after CAR T cell therapy for lymphoma and myeloma
Kevin Charles Miller, Patrick Connor Johnson, Jeremy S Abramson, et al.
Transplantation and Cellular Therapy
|
February 15, 2026
Incidence of and Risk Factors for Delayed Engraftment after Post-Transplant Cyclophosphamide
Lauren Scarpetti, Daniel E Schwartz, Weixing Huang, et al.
Blood
|
April 21, 2021
Primary resistance to CD19-directed chimeric antigen receptor T-cell therapy in T-cell/histiocyte-rich large B-cell lymphoma
Jonathan A Trujillo, James Godfrey, Yifei Hu, et al.
Blood Advances
|
June 25, 2025
Invasive fungal disease is rare in patients with relapsed/refractory multiple myeloma treated with BCMA CAR T-cell therapy
Jessica S Little, Angelica Medina Pena, E Bridget Kim, et al.
Journal for Immunotherapy of Cancer
|
May 9, 2024
Stealth transgenes enable CAR-T cells to evade host immune responses
Korneel Grauwet, Trisha Berger, Michael C Kann, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
January 25, 2020
Acute Kidney Injury and Electrolyte Abnormalities After Chimeric Antigen Receptor T-Cell (CAR-T) Therapy for Diffuse Large B-Cell Lymphoma
Shruti Gupta, Harish Seethapathy, Ian A Strohbehn, et al.
Bone Marrow Transplantation
|
October 11, 2023
Low incidence of engraftment syndrome following allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide
Daniel J Ikeda, Zachariah DeFilipp, Kerry Collier, et al.
Page
of 12